枫下家园 / 医药保健 / Pfizer to Ask US Regulators to Authorize Second Booster Due to Waning Effectiveness: CEO
-sailor(Ocean & Mountain);
2022-3-11{699}(#14436441@0)+6
Pfizer plans to ask U.S. regulators to grant emergency use authorization for a second booster of its COVID-19 ...
纽时报道，CDC隐瞒了很大部分数据没公布，50岁以下的打了booster没啥区别。The C.D.C. Isn’t Publishing Large Portions of the Covid Data It Collects
-blueskygg(Grass);
2022-3-12{527}(#14437094@0)+2
The agency has withheld critical data on boosters, hospitalizations and, until recently, wastewater analyses.
